Two trends—legal cannabis markets expanding and millennials drinking less—are converging, with major implications for both the cannabis and alcoholic beverage industries, and perhaps society more generally, if cannabis gradually supplants alcohol as the intoxicant of choice. For several years, millennials and Gen Z adults in the U.S., Canada and... Read more

Last week, South Dakota became the first state to place medical and adult-use cannabis legalization measures on the same ballot, a situation that has its challenges, as well as unique opportunities, according to Marijuana Policy Project (MPP) Deputy Director Matthew Schweich. “It’s exciting that we’re able to make progress... Read more

Last week, South Dakota became the first state to place medical and adult-use cannabis legalization measures on the same ballot, a situation that has its challenges, as well as unique opportunities, according to Marijuana Policy Project (MPP) Deputy Director Matthew Schweich. “It’s exciting that we’re able to make progress... Read more

Heading in to the first day of adult-use cannabis sales in Illinois Jan. 1, the team at Illinois Supply & Provisions estimated that they would have five to 10 times more customers than a typical day at their two dispensaries, which were founded under the previous state medical program... Read more

As 2019 came to a close—a year defined, in many ways, by a sharp rise in cannabis research interest—a report from a team of Italian researchers in the journal Nature on the first-ever isolation of two newly named natural cannabinoids: Δ9-tetrahydrocannabiphorol (THCP) and cannabidiphorol (CBDP).  The structural identification and... Read more

Heading in to the first day of adult-use cannabis sales in Illinois Jan. 1, the team at Illinois Supply & Provisions estimated that they would have five to 10 times more customers than a typical day at their two dispensaries, which were founded under the previous state medical program... Read more

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 9, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a pre-clinical study held at the company’s High Throughput Screening (HTS) lab facilities in Israel, preliminary findings show that the cannabinoid Cannabigerol (CBG) was shown to... Read more

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 9, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a pre-clinical study held at the company’s High Throughput Screening (HTS) lab facilities in Israel, preliminary findings show that the cannabinoid Cannabigerol (CBG) was shown to... Read more

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 9, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a pre-clinical study held at the company’s High Throughput Screening (HTS) lab facilities in Israel, preliminary findings show that the cannabinoid Cannabigerol (CBG) was shown to... Read more

As 2019 came to a close—a year defined, in many ways, by a sharp rise in cannabis research interest—a report from a team of Italian researchers in the journal Nature on the first-ever isolation of two newly named natural cannabinoids: Δ9-tetrahydrocannabiphorol (THCP) and cannabidiphorol (CBDP).  The structural identification and... Read more